Loading clinical trials...
Loading clinical trials...
Randomized Clinical Study of Haplo-Identical Donors Versus Unrelated Donors in Hematopoietic Stem Cell Transplant Patients With Acute Myeloid Leukemia
Conditions
Interventions
allogeneic stem cell transplantation with a haplo-identical family donor graft
allogeneic stem cell transplantation with a matched unrelated donor graft
Locations
9
Austria
Medical University of Vienna
Vienna, Austria
Princess Margaret Cancer Centre
Toronto, Ontario, Canada
Oslo University Hospital
Oslo, Norway
Pavlov First Saint-Petersburg State Medical University
Saint Petersburg, Russia
Sahlgrenska University Hospital
Gothenburg, Sweden
Linköping University Hospital
Linköping, Sweden
Start Date
November 12, 2019
Primary Completion Date
August 26, 2022
Completion Date
August 26, 2022
Last Updated
April 5, 2023
NCT06285890
NCT06220162
NCT04065399
NCT06484062
NCT04628026
NCT06994676
Lead Sponsor
Karolinska Institutet
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions